View all research projects
Research project

Production of Technology Assessment Reviews (TARs) for the National Institute of Health Research (NIHR) 2022-2027

Staff

Lead researchers

Professor Joanne Lord

Director of SHTAC

Research interests

  • Joanne has research interests in health economic evaluation and decision modelling.
  • She has worked on a wide range of applied cost-effectiveness studies, including:
  • a review of newborn screening for inborn errors of metabolism;trials of diagnosis, patient education, structured decision-making and therapeutic interventions for arthritis and back pain;evaluations of diagnostic tests, preventive treatment and contact tracing for tuberculosis;a model of geographic allocation of resources for control of Chagas disease in Central America; andanalyses relating to the prevention and treatment of cardiovascular diseases. Her methodological contributions include an MRC funded project on whole pathway modelling for NICE clinical guidelines and an economic perspective on test evaluation. She has also contributed to health outcome and quality of life studies.
Connect with Joanne

Email: J.Lord@soton.ac.uk

Other researchers

Dr Jonathan Shepherd PhD

Principal Research Fellow
Connect with Jonathan

Email: Jonny.Shepherd@soton.ac.uk

Collaborating research institutes, centres and groups

Research outputs

Mirikizumab for treating moderately to severely active ulcerative colitis
Karen Pickett, Neelam Kalita, Emma Maund, Jaime Peters, Marcia Takahashi & Joanna Picot, 2023
Type: report
Bimekizumab for treating active psoriatic arthritis
David Alexander Scott, Karen Pickett, Keith Cooper, Fay Chinnery & Joanna Picot, 2023
Type: report
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy
Joanne Lord, Lois Woods, Marcia Tomie Takahashi & Geoff Frampton, 2023
Type: report
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
Lorna Hazell, Keith Cooper, Fay Chinnery, Karen Pickett, David Alexander Scott & Jonathan Shepherd, 2023
Type: report
Daratumumab in combination with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (review of TA573)
Inês Ribeiro, Emma Maund, Neelam Kalita, David Alexander Scott & Jo Picot, 2023
Type: report